Mefloquine the drug's very long half-life, the Centers for Disease Control originally recommended a mefloquine dosage of 250 mg every two weeks; however, this caused an unacceptably high malaria rate in the Peace Corps volunteers who participated in the approval study, so the drug regimen was switched to once a week. The first randomized, controlled trial on a mixed population was performed in 2001. Prophylaxis with mefloquine was compared to prophylaxis with atovaquone-proguanil. Roughly 67% of participants in the mefloquine arm reported greater than or equal to one adverse event, vs 71% in the atovaquone-proguanil arm. In the mefloquine arm, 5%
International Association for the Treatment of Sexual Offenders offender sample from Austria". Every profession has their own standards of care, but the following treatments are a few standards of care that are used as a set of guidelines for any and all professions. Two types of treatment commonly used for the treatment of sexual offenders include psychological and biomedical treatment. The psychological treatment includes different therapies that were made to treat sexual offenders. Both of the different treatments are based on different psychological and psychiatric theories that target the initial paraphilia sexual offending. The psychological and psychiatric care are provided in different forms. The different forms can be